OQS
PRVA icon

Occudo Quantitative Strategies’s Privia Health PRVA Stock Holding History

Occudo Quantitative Strategies’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Sell
12,140
-9,943
-45% -$230K 0.02% 594
2026
Q1 		$549K Buy
+22,083
New +$498K 0.03% 483
2025
Q3 		– Sell
-30,040
Closed -$691K – 830
2025
Q2 		$691K Buy
+30,040
New +$696K 0.08% 307
2025
Q1 		– Sell
-10,567
Closed -$207K – 868
2024
Q4 		$207K Buy
+10,567
New +$209K 0.04% 574
2023
Q4 		– Sell
-43,320
Closed -$996K – 1119
2023
Q3 		$996K Buy
+43,320
New +$1.1M 0.13% 254
2023
Q1 		– Sell
-78,157
Closed -$1.77M – 1139
2022
Q4 		$1.77M Sell
78,157
-4,594
-6% -$128K 0.21% 144
2022
Q3 		$2.82M Buy
+82,751
New +$3.06M 0.22% 122

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Occudo Quantitative Strategies's PRVA Position: Q2 2026 in Review

Occudo Quantitative Strategies reduced its Privia Health (PRVA) stake by 45% in Q2 2026, selling an estimated $230K and leaving 12,140 shares worth $312K. The position accounts for 0.02% of the portfolio, ranked #594.

Occudo Quantitative Strategies first reported a position in PRVA in Q3 2022 and has held it in 7 quarters since. The position peaked at $2.82M in Q3 2022. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Occudo Quantitative Strategies held 12,140 shares of Privia Health worth $312K as of Q2 2026.
  • Occudo Quantitative Strategies sold 9,943 Privia Health shares in Q2 2026, an estimated $230K.
  • Privia Health made up 0.02% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #594 holding.
  • Occudo Quantitative Strategies first reported a position in Privia Health in Q3 2022 and has held it in 7 quarters since.
  • Occudo Quantitative Strategies's Privia Health position peaked at $2.82M in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.